Brokerages Set Ardent Health Partners, LLC (NYSE:ARDT) Price Target at $20.75

Shares of Ardent Health Partners, LLC (NYSE:ARDT) have been given an average rating of “Buy” by the thirteen analysts that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $20.75.

A number of research firms have weighed in on ARDT. Stephens reaffirmed an “overweight” rating and set a $22.00 price objective on shares of Ardent Health Partners in a report on Tuesday, April 1st. Mizuho decreased their price objective on Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, April 9th. Morgan Stanley decreased their price objective on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Royal Bank of Canada reaffirmed an “outperform” rating and set a $21.00 price objective on shares of Ardent Health Partners in a report on Thursday. Finally, Guggenheim lifted their price objective on Ardent Health Partners from $16.00 to $18.00 and gave the company a “buy” rating in a report on Friday, May 9th.

Ardent Health Partners Trading Up 1.1%

Shares of ARDT opened at $15.40 on Wednesday. Ardent Health Partners has a 12-month low of $11.31 and a 12-month high of $20.72. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The firm has a market capitalization of $2.20 billion and a price-to-earnings ratio of 9.45. The stock’s 50-day moving average price is $13.13 and its 200 day moving average price is $14.86.

Ardent Health Partners (NYSE:ARDT) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.08. The firm had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.50 billion. As a group, research analysts predict that Ardent Health Partners will post 1.23 earnings per share for the current year.

Institutional Trading of Ardent Health Partners

A number of institutional investors have recently bought and sold shares of ARDT. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Ardent Health Partners during the 4th quarter worth about $27,000. US Bancorp DE bought a new position in shares of Ardent Health Partners during the 4th quarter worth about $31,000. R Squared Ltd bought a new position in shares of Ardent Health Partners during the 4th quarter worth about $37,000. Morse Asset Management Inc bought a new position in shares of Ardent Health Partners during the 1st quarter worth about $36,000. Finally, New York State Common Retirement Fund bought a new position in shares of Ardent Health Partners during the 4th quarter worth about $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.